MedPath
HSA Approval

Oncotaxel Concentrate and solvent for solution for infusion 40 mg/ ml

SIN13987P

Oncotaxel Concentrate and solvent for solution for infusion 40 mg/ ml

Oncotaxel Concentrate and solvent for solution for infusion 40 mg/ ml

July 15, 2011

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

SOLUTION, CONCENTRATE

INTRAVENOUS

Medical Information

L01CD02

docetaxel

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

S.C. SINDAN-PHARMA S.R.L

S.C. Sindan-Pharma S.R.L (Solvent)

Active Ingredients

Docetaxel

40.0 mg/ ml

Docetaxel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.